BJ
VIRX

BlackRock Japan’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

BlackRock Japan’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-33
Closed -$45K – 1327
2014
Q2 		$45K Sell
33
-35
-51% -$40.6K ﹤0.01% 1055
2014
Q1 		$94K Sell
68
-134
-66% -$156K ﹤0.01% 1072
2013
Q4 		$201K Buy
202
+38
+23% +$39.3K ﹤0.01% 909
2013
Q3 		$171K Hold
164
– – ﹤0.01% 925
2013
Q2 		$179K Buy
+164
New +$183K ﹤0.01% 886

Other funds holding VIRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCP
Lamond Capital Partners San Francisco, California $14.3M AUM 30.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock Japan's VIRX Position: Q3 2014 in Review

BlackRock Japan sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q3 2014, closing a stake of 33 shares — an estimated $45K sold.

BlackRock Japan first reported a position in VIRX in Q2 2013 and held it in 5 quarters. The position peaked at $201K in Q4 2013. 104 funds tracked by Wall St. Rank hold VIRX as of Q3 2014.

  • BlackRock Japan reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • BlackRock Japan sold 33 Viracta Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $45K.
  • BlackRock Japan first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
  • BlackRock Japan's Viracta Therapeutics, Inc. Common Stock position peaked at $201K in Q4 2013.
  • 104 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.